Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Sun, 19 Nov 17 19:55:54 +0000 Sun, 19 Nov 17 19:55:54 +0000 FDA Expands Approval of Kidney Cancer Treatment to Recurrence Prevention http://www.pharmacytimes.com/product-news/fda-expands-approval-of-kidney-cancer-treatment-to-recurrence-prevention http://www.pharmacytimes.com/product-news/fda-expands-approval-of-kidney-cancer-treatment-to-recurrence-prevention Officials with the FDA have expanded the approval of sunitinib malate (Sutent, Pfizer) for adjuvant treatment in adult patients who are at high risk of kidney cancer returning after kidney removal.<br /> &nbsp; Fri, 17 Nov 17 21:55:00 +0000 The Role of the Pharmacist in Heart Failure Management http://www.pharmacytimes.com/news/the-role-of-the-pharmacist-in-heart-failure-management http://www.pharmacytimes.com/news/the-role-of-the-pharmacist-in-heart-failure-management In this clip taken at the American Heart Association 2017 Scientific Sessions, Amar Bhakta, MD, from Rush University Medical Center, explains the crucial role that pharmacists play in the management of heart failure. Pharmacists are in a unique position to provide patient education, ensure medication adherence, and assess the patient&#39;s symptoms.&nbsp; Fri, 17 Nov 17 14:38:00 +0000 Team-Based Pathway Prevents Heart Failure Readmissions http://www.pharmacytimes.com/news/teambased-pathway-prevents-heart-failure-readmissions http://www.pharmacytimes.com/news/teambased-pathway-prevents-heart-failure-readmissions In this clip taken at the American Heart Association&#39;s 2017 Scientific Sessions, Amar Bhakta, MD, of Rush University Medical Center, discusses the results from his hospital&#39;s clinical pathway for heart failure, which includes using multidisciplinary teams to prevent and reduce hospital readmissions.&nbsp; Fri, 17 Nov 17 13:00:00 +0000 FDA Approves New Hemophilia A Treatment http://www.pharmacytimes.com/product-news/fda-approves-new-hemophilia-a-treatment http://www.pharmacytimes.com/product-news/fda-approves-new-hemophilia-a-treatment Officials with the FDA have approved emicizumab-kxwh (Hemlibra, Genentech) as a treatment for patients with hemophilia A who have factor VIII inhibitors, according to a press release from the agency.<br /> &nbsp; Thu, 16 Nov 17 21:43:00 +0000 FDA OKs Treatment for Advanced Follicular Lymphoma http://www.pharmacytimes.com/product-news/fda-oks-treatment-for-advanced-follicular-lymphoma http://www.pharmacytimes.com/product-news/fda-oks-treatment-for-advanced-follicular-lymphoma Officials with the FDA have approved&nbsp;obinutuzumab&nbsp;(Gazyva, Genentech) in combination with chemotherapy, followed by obinutuzumab alone, for the first-line treatment of patients with advanced follicular lymphoma, according to the company&#39;s press release.&nbsp; Thu, 16 Nov 17 21:40:00 +0000 How Will the New BP Guidelines Impact Prescribing Rates for People with Hypertension? http://www.pharmacytimes.com/news/how-will-the-new-bp-guidelines-impact-prescribing-rates-for-people-with-hypertension http://www.pharmacytimes.com/news/how-will-the-new-bp-guidelines-impact-prescribing-rates-for-people-with-hypertension In this clip taken at the 2017 American Heart Association Meeting, Robert Carey, MD, of the University of Virginia discusses the expected increases in the population from the 2003 and 2017 guideline recommendations on hypertension. Thu, 16 Nov 17 15:52:00 +0000 FDA Approves Treatment for Rare Genetic Enzyme Disorder http://www.pharmacytimes.com/product-news/fda-approves-treatment-for-rare-genetic-enzyme-disorder http://www.pharmacytimes.com/product-news/fda-approves-treatment-for-rare-genetic-enzyme-disorder Officials with the FDA today approved the first treatment for mucopolysaccharidosis type VII (MPS VII), a rare genetic enzyme disorder, also called Sly syndrome. Wed, 15 Nov 17 21:06:00 +0000 FDA OKs Marketing of Device to Reduce Opioid Withdrawal Symptoms http://www.pharmacytimes.com/product-news/fda-oks-marketing-of-device-to-reduce-opioid-withdrawal-symptoms http://www.pharmacytimes.com/product-news/fda-oks-marketing-of-device-to-reduce-opioid-withdrawal-symptoms Officials with the FDA have permitted marketing of the first device for use in reducing symptoms of opioid withdrawal.<br /> &nbsp; Wed, 15 Nov 17 17:15:00 +0000 An Intervention to Help Patients With Chronic Metabolic Conditions Adhere to Medications http://www.pharmacytimes.com/news/an-intervention-to-help-patients-with-chronic-metabolic-conditions-adhere-to-medications http://www.pharmacytimes.com/news/an-intervention-to-help-patients-with-chronic-metabolic-conditions-adhere-to-medications At the American Heart Association&#39;s 2017 Scientific Sessions, Niteesh Kumar Choudhry, MD, PhD, Associate Professor at Harvard Medical School, presented the results of a study that evaluated a technology-enabled intervention conducted by pharmacists to help patients with chronic metabolic conditions adhere to their medications.&nbsp; Wed, 15 Nov 17 17:04:00 +0000 Negotiated Interviewing Techniques Help Pharmacists Determine Medication Adherence Barriers http://www.pharmacytimes.com/news/negotiated-interviewing-techniques-help-pharmacists-determine-medication-adherence-barriers http://www.pharmacytimes.com/news/negotiated-interviewing-techniques-help-pharmacists-determine-medication-adherence-barriers At the American Heart Association&#39;s 2017 Scientific Sessions, Niteesh Kumar Choudhry, MD, PhD, Associate Professor at Harvard Medical School, explained how pharmacists can use a behaviorally tailored method of patient interviewing to assess patients&#39; adherence barriers.&nbsp; Wed, 15 Nov 17 15:29:00 +0000 FDA OKs Treatment for Severe Eosinophilic Asthma http://www.pharmacytimes.com/product-news/fda-oks-treatment-for-severe-eosinophilic-asthma http://www.pharmacytimes.com/product-news/fda-oks-treatment-for-severe-eosinophilic-asthma Officials with the FDA have approved benralizumab (Fasenra, AstraZeneca) for the add-on maintenance treatment of patients with severe eosinophilic asthma aged 12 years and older. Wed, 15 Nov 17 13:00:00 +0000 FDA Issues Warning About Kratom Use http://www.pharmacytimes.com/product-news/fda-issues-warning-about-kratom-use http://www.pharmacytimes.com/product-news/fda-issues-warning-about-kratom-use Officials with the FDA have issued a public health advisory on kratom, warning consumers about the potential risks associated with its use.<br /> &nbsp; Tue, 14 Nov 17 20:50:00 +0000 Nonphysician Team Members in Blood Pressure Assessment: What's the Role? http://www.pharmacytimes.com/news/nonphysician-team-members-in-blood-pressure-assessment-whats-the-role http://www.pharmacytimes.com/news/nonphysician-team-members-in-blood-pressure-assessment-whats-the-role In this clip, Dr. Whelton discusses the guideline&#39;s emphasis on a team-based approach to assessing and treating hypertension in patients.&nbsp; Tue, 14 Nov 17 16:57:00 +0000 New Hypertension Guidelines Lower Starting Point for High Blood Pressure http://www.pharmacytimes.com/news/new-hypertension-guidelines-lower-starting-point-for-high-blood-pressure http://www.pharmacytimes.com/news/new-hypertension-guidelines-lower-starting-point-for-high-blood-pressure The guidelines, developed by the American Heart Association and the American College of Cardiology, lower the starting point for high blood pressure.&nbsp; Tue, 14 Nov 17 14:24:00 +0000 Study: Sudden Cardiac Death Risk May Be Higher in Younger Patients with Diabetes http://www.pharmacytimes.com/news/study-sudden-cardiac-death-risk-may-be-higher-in-younger-patients-with-diabetes http://www.pharmacytimes.com/news/study-sudden-cardiac-death-risk-may-be-higher-in-younger-patients-with-diabetes Children and young adults with diabetes may have a 7-fold increased risk of sudden cardiac death than those without diabetes. Tue, 14 Nov 17 14:00:00 +0000 The Role of Pharmacy Benefit Managers in American Health Care: Pharmacy Concerns and Perspectives: Part 1 http://www.pharmacytimes.com/news/the-role-of-pharmacy-benefit-mangers-in-american-health-care-pharmacy-concerns-and-perspectives-part-1 http://www.pharmacytimes.com/news/the-role-of-pharmacy-benefit-mangers-in-american-health-care-pharmacy-concerns-and-perspectives-part-1 Rising health care expenditures within the United States has been a major focus of policy makers, business owners, and individuals for years.<br /> &nbsp; Tue, 14 Nov 17 13:00:00 +0000 Former Lilly President Picked to Head HHS http://www.pharmacytimes.com/news/former-lilly-president-picked-to-head-hhs http://www.pharmacytimes.com/news/former-lilly-president-picked-to-head-hhs President Trump has nominated Alex M. Azar II to be the next secretary of the United States Department of Health and Human Services. Mon, 13 Nov 17 22:00:00 +0000 EMPA-REG Trial: Implications for Type 2 Diabetes Treatment, CV Risk Reduction http://www.pharmacytimes.com/news/empareg-trial-implications-for-type-2-diabetes-treatment-cv-risk-reduction http://www.pharmacytimes.com/news/empareg-trial-implications-for-type-2-diabetes-treatment-cv-risk-reduction In this clip, Eliot A. Brinton, MD, FAHA, FNLA, president of the Utah Lipid Center, discusses how the EMPA-REG trial is a huge step forward for health care providers being able to treat patients with type 2 diabetes with medications that also reduce cardiovascular risk. Mon, 13 Nov 17 20:07:00 +0000 Digital Tracking Pill, Expanded Indication for Schizophrenia Treatments Win FDA Approvals http://www.pharmacytimes.com/product-news/fda-approves-cariprazine-for-maintenance-treatment-of-schizophrenia http://www.pharmacytimes.com/product-news/fda-approves-cariprazine-for-maintenance-treatment-of-schizophrenia FDA officials took 2 steps today that will extend and facilitate treatment options for patients with schizophrenia and other mental health conditions. Mon, 13 Nov 17 16:21:00 +0000 Low Sodium-DASH Diet Combo Best for Hypertensive Adults? http://www.pharmacytimes.com/news/low-sodiumdash-diet-combo-best-for-hypertensive-adults http://www.pharmacytimes.com/news/low-sodiumdash-diet-combo-best-for-hypertensive-adults A low sodium-DASH diet combination lowers blood pressure (BP) in adults with hypertension, according to the results of preliminary research at the American Heart Association&rsquo;s (AHA) Scientific Sessions 2017.<br /> &nbsp; Mon, 13 Nov 17 16:16:00 +0000 FDA Approves First 2-Dose Hepatitis B Vaccine http://www.pharmacytimes.com/product-news/fda-approves-first-2dose-hepatitis-b-vaccine http://www.pharmacytimes.com/product-news/fda-approves-first-2dose-hepatitis-b-vaccine Officials with the FDA have approved an adjuvanted hepatitis B vaccine, recombinant &nbsp;[Heplisav-B, Dynavax]&nbsp; for the prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older. Fri, 10 Nov 17 21:09:00 +0000 National Association of Specialty Pharmacy Voices Support for #APharmacistIs Campaign http://www.pharmacytimes.com/news/national-association-of-specialty-pharmacy-voices-support-for-apharmacistis-campaign http://www.pharmacytimes.com/news/national-association-of-specialty-pharmacy-voices-support-for-apharmacistis-campaign <em>Pharmacy Times</em> and <em>Specialty Pharmacy Times</em> recently announced the launch of a new social media campaign to spread awareness about the work pharmacists do to improve their patients&#39; lives.&nbsp; Fri, 10 Nov 17 15:16:00 +0000 5 New FDA Approvals to Know from October 2017 http://www.pharmacytimes.com/news/5-new-fda-approvals-to-know-from-october-2017 http://www.pharmacytimes.com/news/5-new-fda-approvals-to-know-from-october-2017 Learn about the new products and expanded indications approved by the FDA in October 2017. Fri, 10 Nov 17 15:00:00 +0000 NCODA: Filling the Gaps in Patient Coverage, Education of Oral Chemo Treatments http://www.pharmacytimes.com/news/ncoda-filling-the-gaps-in-patient-coverage-education-of-oral-chemo-treatments http://www.pharmacytimes.com/news/ncoda-filling-the-gaps-in-patient-coverage-education-of-oral-chemo-treatments Fri, 10 Nov 17 14:00:00 +0000 FDA Approves New Indication for Auryxia http://www.pharmacytimes.com/product-news/fda-approves-new-indication-for-auryxia http://www.pharmacytimes.com/product-news/fda-approves-new-indication-for-auryxia Tue, 07 Nov 17 21:37:00 +0000